103 related articles for article (PubMed ID: 17692907)
1. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
Zhou XC; Dowdy SC; Podratz KC; Jiang SW
Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
[TBL] [Abstract][Full Text] [Related]
2. Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.
Yang S; Jia Y; Liu X; Winters C; Wang X; Zhang Y; Devor EJ; Hovey AM; Reyes HD; Xiao X; Xu Y; Dai D; Meng X; Thiel KW; Domann FE; Leslie KK
Oncotarget; 2014 Oct; 5(20):9783-97. PubMed ID: 25229191
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive DNA methylation-based testing for the diagnosis of endometrial cancer.
St Laurent J; Elias KM
Lancet Oncol; 2023 Dec; 24(12):1291-1292. PubMed ID: 37944539
[No Abstract] [Full Text] [Related]
4. Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.
Wang SF; Du CY; Li M; Wen B; Shen QJ; Ma F; Zhang L; Deng H
Technol Cancer Res Treat; 2024; 23():15330338241242637. PubMed ID: 38584417
[No Abstract] [Full Text] [Related]
5. Shining a spotlight on m6A and the vital role of RNA modification in endometrial cancer: a review.
Jin Z; Sheng J; Hu Y; Zhang Y; Wang X; Huang Y
Front Genet; 2023; 14():1247309. PubMed ID: 37886684
[TBL] [Abstract][Full Text] [Related]
6. The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review.
Indumati S; Apurva B; Gaurav G; Nehakumari S; Nishant V
J Reprod Infertil; 2023; 24(3):147-165. PubMed ID: 37663424
[TBL] [Abstract][Full Text] [Related]
7. Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications.
Inoue F; Sone K; Toyohara Y; Takahashi Y; Kukita A; Hara A; Taguchi A; Tanikawa M; Tsuruga T; Osuga Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669072
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data.
Huo X; Sun H; Cao D; Yang J; Peng P; Yu M; Shen K
Sci Rep; 2019 Jul; 9(1):9924. PubMed ID: 31289358
[TBL] [Abstract][Full Text] [Related]
9. Gene Promoter Methylation in Endometrial Carcinogenesis.
Cornel KMC; Wouters K; Van de Vijver KK; van der Wurff AAM; van Engeland M; Kruitwagen RFPM; Pijnenborg JMA
Pathol Oncol Res; 2019 Apr; 25(2):659-667. PubMed ID: 30430425
[TBL] [Abstract][Full Text] [Related]
10. Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.
Ying J; Xu T; Wang Q; Ye J; Lyu J
Epigenetics; 2018; 13(5):490-504. PubMed ID: 29912667
[TBL] [Abstract][Full Text] [Related]
11. A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results.
Kottaridi C; Koureas N; Margari N; Terzakis E; Bilirakis E; Pappas A; Chrelias C; Spathis A; Aga E; Pouliakis A; Panayiotides I; Karakitsos P
Biomed Res Int; 2015; 2015():756359. PubMed ID: 26504828
[TBL] [Abstract][Full Text] [Related]
12. Malignant tumors of the uterine corpus: molecular background of their origin.
Brany D; Dvorska D; Nachajova M; Slavik P; Burjanivova T
Tumour Biol; 2015 Sep; 36(9):6615-21. PubMed ID: 26307392
[TBL] [Abstract][Full Text] [Related]
13. Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization.
Tian G; Mi J; Wei X; Zhao D; Qiao L; Yang C; Li X; Zhang S; Li X; Wang B
Sci Rep; 2015 Jun; 5():11394. PubMed ID: 26096712
[TBL] [Abstract][Full Text] [Related]
14. Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma.
Chen H; Zhang C; Sheng Y; Yao S; Liu Z; Zhang C; Zhang T
Am J Cancer Res; 2015; 5(1):180-90. PubMed ID: 25628929
[TBL] [Abstract][Full Text] [Related]
15. Discovery and validation of methylation markers for endometrial cancer.
Wentzensen N; Bakkum-Gamez JN; Killian JK; Sampson J; Guido R; Glass A; Adams L; Luhn P; Brinton LA; Rush B; d'Ambrosio L; Gunja M; Yang HP; Garcia-Closas M; Lacey JV; Lissowska J; Podratz K; Meltzer P; Shridhar V; Sherman ME
Int J Cancer; 2014 Oct; 135(8):1860-8. PubMed ID: 24623538
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies on histone deacetylase inhibitors as therapeutic reagents for endometrial and ovarian cancers.
Singh BN; Zhou H; Li J; Tipton T; Wang B; Shao G; Gilbert EN; Li Q; Jiang SW
Future Oncol; 2011 Dec; 7(12):1415-28. PubMed ID: 22112317
[TBL] [Abstract][Full Text] [Related]
17. Progesterone: the ultimate endometrial tumor suppressor.
Yang S; Thiel KW; Leslie KK
Trends Endocrinol Metab; 2011 Apr; 22(4):145-52. PubMed ID: 21353793
[TBL] [Abstract][Full Text] [Related]
18. Genetics of endometrial cancers.
Okuda T; Sekizawa A; Purwosunu Y; Nagatsuka M; Morioka M; Hayashi M; Okai T
Obstet Gynecol Int; 2010; 2010():984013. PubMed ID: 20396392
[TBL] [Abstract][Full Text] [Related]
19. HtrA serine proteases as potential therapeutic targets in cancer.
Chien J; Campioni M; Shridhar V; Baldi A
Curr Cancer Drug Targets; 2009 Jun; 9(4):451-68. PubMed ID: 19519315
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
